Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Playground Global
Deal Size : $35.0 million
Deal Type : Series A Financing
Details : Atomic AI’s proprietary engine leverages RNA structural biology and AI foundation models to enable the design of RNA-targeting small molecules and RNA-based medicines.
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Undisclosed
January 25, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Playground Global
Deal Size : $35.0 million
Deal Type : Series A Financing